Biolegend, 640930, APC Annexin V Apoptosis Detection Kit with 7-AAD, 100tests

BioLegend's APC Annexin V Apoptosis Detection Kit with 7-AAD has been specifically designed for the identification of apoptotic and necrotic cells. Annexin V (or Annexin A5) is a member of the annexin family of intracellular proteins that binds to phosphatidylserine (PS) in a calcium-dependent manner. PS is normally only found on the intracellular leaflet of the plasma membrane in healthy cells, but during early apoptosis, membrane asymmetry is lost and PS translocates to the external leaflet. Fluorochrome-labeled Annexin V can then be used to specifically target and identify apoptotic cells. Annexin V Binding Buffer is recommended for use with Annexin V staining. Annexin V binding alone cannot differentiate between apoptotic and necrotic cells. To help distinguish between the necrotic and apoptotic cells we recommend use of our 7-amino-actinomycin D (7-AAD) solution. Early apoptotic cells will exclude 7-AAD, while late stage apoptotic cells will stain positively, due to the passage of these dyes into the nucleus where they bind to DNA. 7-AAD (7-amino-actinomycin D) has a high DNA binding constant and is efficiently excluded by intact cells. It is useful for DNA analysis and dead cell discrimination during flow cytometric analysis. When excited by 488 laser light, 7-AAD fluorescence is detected in the far red range of the spectrum (650 nm long-pass filter).
100tests
Verified Reactivity: Human, Mouse, Rat
Reported Reactivity: Other Species
Concentration: Lot-specific (to obtain lot-specific concentration and expiration, please enter the lot number in our Certificate of Analysis online tool.)
Storage & Handling: Store between 2°C and 8°C. Do not freeze. Caution: 7-AAD is a potential carcinogen. It is recommended that the user wear protective clothing, gloves, and eye/face protection in order to avoid contact with skin and eyes.
Application: FC - Quality tested
Excitation Laser: Red Laser (633 nm)
Application Notes: Annexin V Staining Wash cells twice with cold BioLegend Cell Staining Buffer (Cat. No. 420201) and then resuspend the desired amount of cells in Annexin V Binding Buffer (Cat. No. 422201) at a concentration of 0.25-1.0 x 107 cells/mL Transfer 100 µL of cell suspension in 5 mL test tube. Add 5 µL of fluorochrome conjugated Annexin V. Stain with a viability dye, such as PI (Cat. No. 421301), 7-AAD (Cat. Nos. 420403 & 420404), or Helix NP dyes (Cat. Nos. 425301, 425303, & 425305), if desired. Gently vortex the cells and incubate for 15 min at RT (25°C) in the dark. Add 400* µL of Annexin V Binding Buffer (Cat. No. 422201) to each tube. *For more concentrated samples, add a minimum of 200 µl of Annexin V Binding Buffer in this step. Analyze by flow cytometry. For a better experience detecting apoptosis, we now recommend Apotracker™. Cell staining with Apotracker™ is Calcium independent. Thus, no special buffers are required, and the protocol can be shortened for single-step co-staining with other reagents.
Application References(PubMed link indicates BioLegend citation): Maciel E, et al. 2014. Arch Biochem Biophys. 548:38. PubMed
Product Citations: Cook ME, et al. 2022. Sci Immunol. 7:eabo0981. PubMed Lamamy J, et al. 2022. Front Immunol. 13:1054425. PubMed Nakamura H, et al. 2023. PLoS One. 18:e0282227. PubMed Shi P, et al. 2023. Commun Biol. 6:334. PubMed Huang F, et al. 2023. Int J Mol Sci. 24:. PubMed Saez-Ayala M, et al. 2023. Nat Commun. 14:3079. PubMed Balood M, et al. 2022. Nature. 611:405. PubMed Català C, et al. 2022. iScience. 25:105078. PubMed Chiarella E, et al. 2020. Heliyon. 6:e04020. PubMed Chen CC, et al. 2020. Cancer Cell. 37:71. PubMed Paz H, et al. 2018. J Exp Clin Cancer Res. 37:67. PubMed Rutherford TR, et al. 2021. Cell Death Dis. 12:872. PubMed Fluckiger A, et al. 2016. Oncogene. 10.1038/onc.2015.523. PubMed Krone A, et al. 2022. Sci Rep. 218:. PubMed Papadas A, et al. 2022. Cell Rep. 40:111201. PubMed Cribioli E, et al. 2022. Front Immunol. 13:976628. PubMed Huangfu J, et al. 2021. Cell Death Dis. 12:386. PubMed Li W, et al. 2022. PeerJ. 10:e14086. PubMed Gómez-Aleza C, et al. 2020. Nat Commun. 4.857638889. PubMed Broggi A, et al. 2017. Nat Immunol. 18:1084. PubMed Wu L, et al. 2022. Theranostics. 12:842. PubMed Yao F, et al. 2021. Nat Commun. 12:7333. PubMed Lee A, et al. 2022. Int J Oncol. 60:. PubMed Chen X, et al. 2021. Theranostics. 11:3392. PubMed Xie J, et al. 2018. Oncol Lett. 16:157. PubMed Vogiatzi F, et al. 2022. Blood Adv. 6:4847. PubMed Dong Y, et al. 2020. J Leukoc Biol. 108:1711. PubMed Li H,et al. 2017. Sci Rep.. 10.1038/s41598-017-13471-4. PubMed Zhuo J, et al. 2021. Cell Death Dis. 12:1084. PubMed Wu H, et al. 2021. Cell Death Discov. 7:225. PubMed Lei J, et al. 2021. Theranostics. 4251:11. PubMed Tanaka T, et al. 2020. Sci Rep. 10:15169. PubMed Dolan M, et al. 2019. PLoS One. 14:e0220101. PubMed Tang Q, et al. 2021. Genes Dev. 35:528. PubMed Gong H, et al. 2019. EBioMedicine. 44:138. PubMed Hu M, et al. 2020. Cancer Immunol Res. 8:1150. PubMed Singh SK, et al. 2021. Oncogene. 40:6153. PubMed Wang Y, et al. 2022. Nat Commun. 13:6663. PubMed Fragoso MF, et al. 2022. Int J Mol Sci. 23:. PubMed Yin S, et al. 2015. Sci Rep. 5: 14432. PubMed Gunda V, et al. 2020. Cancers (Basel). 12:00. PubMed Riebeling T, et al. 2020. Cell Death Differ. . PubMed Peeters R, et al. 2022. Nat Commun. 13:5371. PubMed Leary N, et al. 2022. J Extracell Vesicles. 11:e12197. PubMed Tang J, et al. 2021. Front Genet. 12:666451. PubMed Gourvest M, et al. 2021. Leukemia. . PubMed Huang Z, et al. 2021. Am J Cancer Res. 4287:10. PubMed Tan H, et al. 2022. Acta Pharm Sin B. 12:2348. PubMed Seong BKA, et al. 2021. Cancer Cell. 39:1262. PubMed Li K, et al. 2021. J Exp Med. 218:. PubMed Zhan L, et al. 2021. Exp Ther Med. 22:1082. PubMed Hezkiy EE, et al. 2022. Cells. 11:. PubMed Simula L, et al. 2020. Cell Death Differ. 27:2749. PubMed Corso J, et al. 2016. Proc Natl Acad Sci U S A. 113: 5688 - 5693. PubMed Lei X, et al. 2022. Nat Commun. 13:3882. PubMed Jin X, et al. 2022. iScience. 25:104349. PubMed
Biology Area: Apoptosis/Tumor Suppressors/Cell Death, Cell Biology, Cell Proliferation and Viability, Neuroscience
Gene ID: 308
Regulatory Status: RUO
Other Names: Annexin A5 Apoptosis Detection Kit, Dead, Apoptosis
Q: How is your Annexin made and what sequence does it cover?
A: It is made in E. coli, covering human aa Met1-Asp320.
Q: How does pH and staining temperature affect Annexin V-Phosphatidylserine binding?
A: Annexin-Phosphatidylserine binding is lost below pH 5.2 and with prolonged incubation over a temperature of 42°C.
Q: Why do I need to use Annexin V Binding Buffer?
A: Annexin V binding requires the presence of calcium in the solution.  So, we provide Annexin V Binding Buffer (cat # 422201), which is optimized for the best performance of Annexin V staining.
Q: Can I use RPMI during Annexin V staining?
A: It is best to follow protocol as described on the product data sheet. Moreover, RPMI 1640 has a relatively high concentration of phosphate and low calcium ion concentration, which negatively impacts Annexin binding to its target phosphatidylserine (PS). Measurement of cell death by using Annexin V may also be significantly affected by time of incubation on ice, calcium concentration, and type of medium.
Q: Can I freeze Annexin V conjugates?
A: It should not be frozen as it will lead to loss of biological activity due to dimerization.
Q: Is Annexin V suitable for conjugation with the Maxpar® kit for CyTOF®?
A: Maxpar® Labeling kits require the protein to be partially reduced, so the metal chelate can be introduced through an SH group in the hinge region of the reduced antibody. Human Annexin V contains only one Cysteine which was reported to be chemically inactive. Thus, the Maxpar® labeling protocol would not work with Annexin V, unless a free –SH group can be introduced to Annexin V.  For more information regarding SH-mediated conjugation of Annexin V please consult published papers such as this one.